New preventive treatment shows promise for reducing bleeds in hemophilia a
NCT ID NCT04158648
Summary
This study tested a preventive treatment called emicizumab in people with mild or moderate hemophilia A who do not have inhibitors. The goal was to see if regular injections could safely reduce the number of bleeding episodes. Researchers measured how often participants bled and how the treatment affected their daily activities and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC Location AMC
Amsterdam, 1105 AZ, Netherlands
-
CH de Bicetre
Le Kremlin-Bicêtre, 94275, France
-
Cardiff and Vale NHS Trust
Cardiff, CF14 4XW, United Kingdom
-
Charlotte Maxeke Johannesburg Hospital
Johannesburg, 2193, South Africa
-
Childrens Hospital LA
Los Angeles, California, 90027, United States
-
Cliniques Universitaires St-Luc
Brussels, 1200, Belgium
-
Eastern Health - General Hospital
St. John's, Newfoundland and Labrador, A1B 3V6, Canada
-
Great Ormond street Hospital for Children NHS Foundation Trust
London, WC1N 3HR, United Kingdom
-
Groupe Hospitalier Necker Enfants Malades
Paris, 75015, France
-
Hemophilia of Georgia Center for Bleeding & Clotting Disorders
Atlanta, Georgia, 30308, United States
-
Hopital Cardio-vasculaire Louis Pradel
Bron, 69677, France
-
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
-
Hospital Universitario la Paz
Madrid, 28046, Spain
-
Indiana Hemophilia & Thrombosis center
Indianapolis, Indiana, 46260, United States
-
Instytut Hematologii i Transfuzjologii
Warsaw, 02-776, Poland
-
Kaye Edmonton Clinic
Edmonton, Alberta, T6G 1Z1, Canada
-
Klinikum der Universität München, Campus Innenstadt
München, 80336, Germany
-
Royal Free Hospital
London, NW3 2QG, United Kingdom
-
UZ Leuven Gasthuisberg
Leuven, 3000, Belgium
-
University of Michigan, C.S. Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
Universitätsklinikum Bonn
Bonn, 53127, Germany
-
Washington Institute for Coagulation
Seattle, Washington, 98101, United States
Conditions
Explore the condition pages connected to this study.